doi:10.3969/j.issn.1673-8640.2024.01.013

Abstract

CLC Number:

R373.9

Figures/Tables 3

References 16

[1]	COHEN P A, JHINGRAN A, OAKNIN A, et al. Cervical cancer[J]. Lancet, 2019, 393(10167):169-182. DOI PMID
[2]	SUNG H, FERLAY J, SIEGEL R L, et al. Global Cancer Statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3):209-249. DOI URL
[3]	WALBOOMERS J M, JACOBS M F, MANOS M M, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide[J]. J Pathol, 1999, 189(1):12-19. DOI PMID
[4]	BOSCH F X, BURCHELL A N, SCHIFFMAN M, et al. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia[J]. Vaccine, 2008, 26(Suppl 10):K1-K16. DOI URL
[5]	SIEGEL R L, MILLER K D, WAGLE N S, et al. Cancer statistics,2023[J]. CA Cancer J Clin, 2023, 73(1):17-48. DOI URL
[6]	张亚旭, 崔延伟, 刘紫烟. 核酸分子杂交-流式细胞术检测HPV E6/E7 mRNA初步研究[J]. 检验医学, 2023, 38(1):46-50. DOI
[7]	MCBRIDE A A. Human papillomaviruses:diversity,infection and host interactions[J]. Nat Rev Microbiol, 2022, 20(2):95-108. DOI
[8]	MALIK S, SAH R, MUHAMMAD K, et al. Tracking HPV infection,associated cancer development,and recent treatment efforts-a comprehensive review[J]. Vaccines(Basel), 2023, 11(1):102.
[9]	HUANG W, XU H, HU H, et al. The prevalence of human papillomavirus among women in northern Guangdong Province of China[J]. Sci Rep, 2022, 12(1):13353. DOI PMID
[10]	MA L, LEI J, MA L, et al. Characteristics of women infected with human papillomavirus in a tertiary hospital in Beijing China,2014-2018[J]. BMC Infect Dis, 2019, 19(1):670. DOI
[11]	WANG Y, HAN S, WANG X, et al. Characteristics of human papillomavirus infection among females and the genetic variations of HPV18 and HPV58 in Henan province,China[J]. Sci Rep, 2023, 13(2):2252. DOI
[12]	GUAN P, HOWELL-JONES R, LI N, et al. Human papillomavirus types in 115 789 HPV-positive women:a meta-analysis from cervical infection to cancer[J]. Int J Cancer, 2012, 131(10):2349-2359. DOI URL
[13]	FINDLATER A, BOGOCH I I. Human mobility and the global spread of infectious diseases:a focus on air travel[J]. Trends Parasitol, 2018, 34(9):772-783. DOI URL
[14]	ADDA J. Economic activity and the spread of viral diseases:evidence from high frequency data[J]. Q J Econ, 2016, 131(2):891-941. DOI URL
[15]	宋祎凡, 刘晓雪, 尹遵栋, 等. 2018—2020年中国9-45岁女性人乳头瘤病毒疫苗估算接种率[J]. 中国疫苗和免疫, 2021, 27(5):570-575.
[16]	World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem[EB/OL]. (2020-11-17) [2022-11-22]. https://www.who.int/publications/i/item/9789240014107.

HPV 亚型	总体		2018—2019年		2020—2022年		χ²值	P值
HPV 亚型	例数	百分比/%	例数	百分比/%	例数	百分比/%	χ²值	P值
16	1 418	2.94	647	3.35	771	2.67	18.76	<0.000 1
18	553	1.15	240	1.24	313	1.08	2.58	0.108 0
31	572	1.19	279	1.44	293	1.01	18.25	<0.000 1
33	501	1.04	200	1.03	301	1.04	0.01	0.944 0
HPV 亚型	总体		2018—2019年		2020—2022年		χ²值	P值
HPV 亚型	例数	百分比/%	例数	百分比/%	例数	百分比/%	χ²值	P值
35	355	0.74	153	0.79	202	0.70	1.36	0.243 0
39	846	1.75	397	2.05	449	1.55	16.84	<0.000 1
45	168	0.35	86	0.44	82	0.28	8.68	0.003 0
51	997	2.07	488	2.52	509	1.76	33.38	<0.000 1
52	2 721	5.64	1 089	5.63	1 632	5.65	0.00	0.954 0
56	873	1.81	426	2.20	447	1.55	28.17	<0.000 1
58	1 508	3.12	569	2.94	939	3.25	3.55	0.059 4
59	660	1.37	252	1.30	408	1.41	1.00	0.318 0
66	910	1.89	436	2.26	474	1.64	23.73	<0.000 1
68	745	1.54	415	2.15	330	1.14	76.98	<0.000 1
82	175	0.36	96	0.50	79	0.27	15.98	<0.000 1

HPV 亚型	总体		2018—2019年		2020—2022年		χ²值	P值
HPV 亚型	例数	百分比/%	例数	百分比/%	例数	百分比/%	χ²值	P值
16	1 418	2.94	647	3.35	771	2.67	18.76	<0.000 1
18	553	1.15	240	1.24	313	1.08	2.58	0.108 0
31	572	1.19	279	1.44	293	1.01	18.25	<0.000 1
33	501	1.04	200	1.03	301	1.04	0.01	0.944 0
HPV 亚型	总体		2018—2019年		2020—2022年		χ²值	P值
HPV 亚型	例数	百分比/%	例数	百分比/%	例数	百分比/%	χ²值	P值
35	355	0.74	153	0.79	202	0.70	1.36	0.243 0
39	846	1.75	397	2.05	449	1.55	16.84	<0.000 1
45	168	0.35	86	0.44	82	0.28	8.68	0.003 0
51	997	2.07	488	2.52	509	1.76	33.38	<0.000 1
52	2 721	5.64	1 089	5.63	1 632	5.65	0.00	0.954 0
56	873	1.81	426	2.20	447	1.55	28.17	<0.000 1
58	1 508	3.12	569	2.94	939	3.25	3.55	0.059 4
59	660	1.37	252	1.30	408	1.41	1.00	0.318 0
66	910	1.89	436	2.26	474	1.64	23.73	<0.000 1
68	745	1.54	415	2.15	330	1.14	76.98	<0.000 1
82	175	0.36	96	0.50	79	0.27	15.98	<0.000 1

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 3

References 16

Related Articles 15

Recommended Articles

Metrics

[1]	LU Xinli, LIU Yong, LI Yan, WANG Yingying, AN Ning, LIU Meng. Identification of near full-length genome structures of new HIV-1 recombinant strains [J]. Laboratory Medicine, 2023, 38(11): 1015-1019.
[2]	ZHANG Yaxu, CUI Yanwei, LIU Ziyan. Preliminary research for the determination of HPV E6/E7 mRNA by nucleic acid molecular hybridization-flow cytometry [J]. Laboratory Medicine, 2023, 38(1): 46-50.
[3]	LIU Hongqian, SONG Chaohui, LIANG Qiaomi. Determination and quantitation of blood human papillomavirus DNA in healthy subjects [J]. Laboratory Medicine, 2021, 36(11): 1121-1124.
[4]	ZHANG Yunli, WANG Xin, SHAO Ling, QU Bo, ZHAO Hongmei. Comparison of different nucleic acid extraction methods for the detection of SARS-Cov-2 [J]. Laboratory Medicine, 2021, 36(5): 530-534.
[5]	XUAN Binbin, TAN Meiyu, SUN Hanxiao, SHENG Huiming. Mixed infection status of human papillomavirus,Ureaplasma urealyticum,Chlamydia trachomatis and Neisseria gonorrhoeae in Changning district of Shanghai [J]. Laboratory Medicine, 2020, 35(9): 859-863.
[6]	YAN Jianghong, JA Li, LI Wenhui, YANG Shuo, YAN Xiaotong, ZHAO Mengchuan, GUO Weiwei, LIU Yingye, LIU Zehao, WANG Le. Epidemiological characteristics of EB virus infection in inpatients from Hebei Children's Hospital [J]. Laboratory Medicine, 2020, 35(4): 323-326.
[7]	SHEN Qionghua. Role of HPV DNA typing in the differential diagnosis of cervical lesions and cervical cancer [J]. Laboratory Medicine, 2019, 34(6): 498-501.
[8]	ZHANG Baohua, YU Guixiang, JIANG Yan, PAN Hong, JIANG Xiangning. Performance evaluation of GN13 and NM38 to determine the drug susceptibility of carbapenems against Klebsiella pneumoniae [J]. Laboratory Medicine, 2019, 34(3): 263-266.
[9]	. [J]. Laboratory Medicine, 2019, 34(1): 82-83.
[10]	WEI Shanqiu. Research progress on immune factors related with HIV infectious disease development [J]. Laboratory Medicine, 2015, 30(6): 646-649.
[11]	YAO Rongfeng,ZHAO Xuhong,LI Zhi,XUE Long,XU Guoxiang. Analysis on the infection status of human papilloma virus in women with different ages [J]. , 2014, 29(7): 708-711.
[12]	WU Beiying, CAI Gang, LIN Jiafei, FAN Zhenjia, FAN Qishi.. Clinical significance of monitoring BK virus in transplanting patients [J]. , 2014, 29(5): 493-498.
[13]	NI Yinghua, SHI Youhao.. Application research on virus load and optimal threshold for the detection of high risk HPV DNA in cervical precancerous lesion [J]. , 2014, 29(5): 501-504.
[14]	ZHOU Yan;SONG Binbin;ZHEN Xiaohong;GUO Wei;PAN Baishen. The evaluation of Elecsys HIV Combi reagent in detecting HIV antigen and antibody [J]. , 2011, 26(12): 845-849.
[15]	CHENG Maoling;QIAO Gang. Analysis of the genotyping of hantavirus in Qingdao [J]. , 2011, 26(08): 523-526.